MALAT1 and pancreatic neoplasm: This is the first evidence of MALAT1 expression in FFPE patient tissues of breast, colorectal and pancreatic cancers by chromogenic staining, suggesting that lncRNA MALAT1 is associated with multiple cancers and its use as a therapeutic target should be investigated further.